Table 1.
Characteristics of study population and incidence of forearm hematoma with different clinico-demographic factors
| Patient characteristics | Total (n=1754) | Hematoma | |
|---|---|---|---|
|
| |||
| Present (n=187) | Absent (n=1567) | ||
| Age (mean ± SD, years) | 56.3±10.6 | 56.2±11.3 | 56.3±10.5 |
| Female, n (%) | 312 (17.8%) | 52 (27.8%) | 260 (16.6%) |
| Body weight (mean ± SD, kg) | 64.4±9.0 | 64.2±9.1 | 64.4±9.0 |
| Hypertension, n (%) | 666 (38.0%) | 68 (36.4%) | 598 (38.2%) |
| Diabetes mellitus, n (%) | 622 (35.5%) | 67 (35.8%) | 555 (35.4%) |
| Smoking, n (%) | 570 (32.5%) | 70 (37.4%) | 500 (31.9%) |
| Hemoglobin (mean ± SD, g/dl) | 12.8±1.7 | 12.6±1.9 | 12.7±1.6 |
| Serum Creatinine (mean ± SD, mg/dl) | 1.06±0.46 | 1.02±0.26 | 1.06±0.47 |
| GFR (mean ± SD, ml/min) | 73.9±24.5 | 73.2+22.9 | 74.1±24.7 |
| Homeostasis time, n (%) | |||
| ≤360 min | 802 (45.7%) | 49 (26.2%) | 753 (48.1%) |
| >360 min | 952 (54.3%) | 138 (73.8%) | 814 (51.9%) |
| GFR (ml/min), n (%) | |||
| ≤60 | 542 (30.9%) | 58 (31.0%) | 484 (30.9%) |
| >60 | 1212 (69.1%) | 129 (69.0%) | 1083 (69.1%) |
| Multiple puncture attempts, n (%) | |||
| No | 1091 (62.2%) | 89 (47.6%) | 1002 (63.9%) |
| Yes | 663 (37.8%) | 98 (52.4%) | 565 (36.1%) |
| Contrast volume (ml), n (%) | |||
| <100 ml | 388 (22.1%) | 40 (21.4%) | 348 (22.2%) |
| ≥100 ml | 1366 (77.9%) | 147 (78.6%) | 1219 (77.8%) |
| Sheath size, n (%) | |||
| 5F | 378 (21.6%) | 40 (21.4%) | 338 (21.6%) |
| 6F | 1367 (77.9%) | 140 (74.9%) | 1227 (78.3%) |
| 7F | 9 (0.5%) | 7 (3.7%) | 2 (0.1%) |
| Antiplatelet treatment, n (%) | |||
| Conventional | 1455 (83.0%) | 128 (68.4%) | 1327 (84.7%) |
| Intensive | 299 (17.0%) | 59 (31.6%) | 240 (15.3%) |
| Heparin dose, n (%) | |||
| 5000 units | 380 (21.7%) | 40 (21.4%) | 340 (21.7%) |
| >5000 units | 1374 (78.3%) | 147 (78.6%) | 1227 (78.3%) |
| Diagnostic vs. therapeutic procedure, n (%) | |||
| Angiography | 380 (21.7%) | 40 (21.4%) | 340 (21.7%) |
| Angioplasty | 1374 (78.3%) | 147 (78.6%) | 1227 (78.3%) |
| Complexity of procedure, n (%) | |||
| Simple | 1618 (92.2%) | 153 (81.8%) | 1465 (93.5%) |
| Complex | 136 (7.8%) | 34 (18.2%) | 102 (6.5%) |
Continuous variables are reported in mean (standard deviation). GFR: Glomerular filtration rate; SD: Standard deviation. Intensive antiplatelet therapy: Use of dual antiplatelet therapy containing ticagrelor or prasugrel and/or use of Glycoprotein IIb/IIIa inhibitors.